In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


A Call For Action: Pharma Strategies For Development Of Payor Evidence Programs

Executive Summary

The biopharma industry invests substantially in post-approval studies to convey information about the value of its products to constituents, but the majority of these efforts do not address core, real-world questions raised by payors. A new business model recognizing the strategic value of medical affairs to market access is needed to stem the tide of disappointing reimbursement decisions.


Related Content

Getting Results From Big Data Depends On Trust Between Stakeholders
Big Data Transforming The Role Of Pharma, IBM Analytics Partner Says
Projecting Market Access Success For Early-Stage Pharma Assets: Getting Past The Hurdles
GSK Is Getting Ready For A Return To The ’90s
Pharma/Payor Deals An Important Step In The Shift To Value-Based R&D
Intermune’s Esbriet Flops In Front Of IQWiG
New German Reimbursement Process Splits Opinion Ahead Of First Assessments
A Call For Action: Integrating Payor Requirements Into Phase III Clinical Trials
Pay-For-Performance Hits France As Part Of Cost-Cutting Measures


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts